drugset / Trial / NCT01651273
A Safety Study of BMS-852927 in Subjects With Hypercholesterolemia
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety of BMS-852927 after 28 days of dosing in patients with high cholesterol.
Timeline
- Start
- 2012-11
- Primary completion
- 2013-06
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-852927 | Small molecule | 0.25 mg | Oral |
| Subject | BMS-852927 | Small molecule | 1 mg | Oral |
| Subject | BMS-852927 | Small molecule | 2.5 mg | Oral |